Tag Archives: Operational

Threshold Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial and Operational Results – Yahoo Finance

The “410 trial” is a Phase 1/2 trial in combination with sunitinib in patients with renal cell carcinoma, gastrointestinal stromal tumors or pancreatic neuroendocrine tumors. To date, across all clinical trials, TH-302 has been administered to … Bing News – … Continue reading

Share
Posted in Intestinal Cancer | Tagged , , , , , , , , , , , | Leave a comment

YM BioSciences Releases 2Q Fiscal 2011 Operational and Financial Results – TradingMarkets.com

In addition to demonstrating positive efficacy signals in the approvable endpoints in this indication, splenomegaly and symptomatic improvement, CYT387 also exhibited a promising ability to positively impact anemia, a major life-shortening symptom … Bing News – Full Story →

Share
Posted in Spleen Diseases | Tagged , , , , , , , | Leave a comment